Product News: DRG International ELISA Kit Allows for Effective Hepcidin Detection

07 Jun 2013


DRG International, a leading international medical diagnostic company, continues to excel in the field with their DRG® Hepcidin 25 (C-Terminal) ELISA Kit (EIA-5258). When it was released this kit was the first and only diagnostic kit to measure the hormone Hepcidin. In recent years, scientists discovered that Hepcidin helps regulate the amount of iron in humans. Unbalanced iron level can lead to many common medical conditions including anemia and iron overload diseases and it can occur in chronic kidney disease, inflammation, or diabetes mellitus.

The DRG® Hepcidin 25 (C-Terminal) ELISA Kit is available to medical professionals worldwide, providing a simple, fast and accurate method to test patient Hepcidin levels. The measurement results will offer more information to clinicians to help doctors diagnose and treat medical conditions including iron deficiency diseases, some of the most common diseases worldwide.

"With many health problems related to Hepcidin, the research team at DRG recognized the need to invent a testing kit, and put it in the hands of health professionals across the globe as soon as possible,” stated Dr. Cyril E. Geacintov, Chairman of DRG International. “This kit provides accurate information, is user-friendly, and will help meet the rapidly growing worldwide demand for such a testing kit.”

The new ELISA Hepcidin kit was jointly developed by research teams in the United States and Germany, under the strict standards of DRG International. The Hepcidin ELISA kit is fully patented and available worldwide. It will be showcased at the AACC Conference later this month.